Investigation of the lipid profile in patients with subclinical hypothyroidism
Archives of Medical Laboratory Sciences,
Vol. 3 No. 4 (2017),
26 September 2018
https://doi.org/10.22037/amls.v3i4.22027
Abstract
Background: Hypothyroidism is a thyroid gland-related disorder which causes lipid metabolism disturbance. Subclinical Hypothyroidism (SCH) is a compensatory stage in the course of this disease, in which TSH production increases while the levels of thyroid hormones are in normal or low-normal range. There are no studies about the lipid profile abnormalities in SCH. Therefore, the aim of this study was to evaluate the lipid profile in SCH patients and compare it with normal individuals.
Methods: In this case-control study, subjects were randomly chosen among 800 individuals referred to Neka city hospital in Mazandaran province, Iran in order to routine biochemical and thyroid hormone checkup. Participants were divided into two groups ; cases (n=400) and controls (n=400). Thyroid hormones were measured by ELISA, and lipid profile parameters were evaluated colorimetrically by AutoAnalyzer.
Results: There were no significant differences in age and sex distribution between the two groups. Among the measured thyroid hormones, TSH was significantly different between the two groups (p≤ 0.05). In case of lipid profile, high-density lipoprotein cholesterol (HDL-C) was significantly different between the two groups (p≤ 0.05). However, no significant differences were observed in the amount of low-density lipoprotein cholesterol (LDL-C), triglyceride (TG) and cholesterol (p>0.05).
Conclusion: SCH patients, showed a decrease in HDL-C. It can be concluded that subclinical hypothyroidism similar to hypothyroidism can cause lipid metabolism disturbance.
- hypothyroidism
- thyroid hormones
- lipid profile
- thyroid
How to Cite
References
Shekhar R, Chowdary N, Das M, Vidya D, Prabodh S. Prevalence of subclinical hypothyroidism in coastal Andhra Pradesh. Biomedical Research. 2011;22(4).
Kumar A, Ishran R, Pipliwal PS, Singh G, Verma M. Lipid Profile in Subclinical Hypothyroidism: A Case-control Study.
Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinology and Metabolism Clinics. 2000;29(2):399-415.
Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. The Journal of Clinical Endocrinology & Metabolism. 2000;85(9):2993-3001.
Rodondi N, Den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Jama. 2010;304(12):1365-74.
Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. The Journal of Clinical Endocrinology & Metabolism. 2010;95(4):1734-40.
Althaus B, Staub JJ, LÈCHE ARD, Oberhänsli A, Stähelin H. LDL/HDL‐changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clinical endocrinology. 1988;28(2):157-63.
Mirzaei M, Truswell A, Taylor R, Leeder SR. Coronary heart disease epidemics: not all the same. Heart. 2009;95(9):740-6.
Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Annals of internal medicine. 1971;74(1):1-12.
Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. International journal of cardiology. 2008;125(1):41-8.
McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011;21(8):837-43.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972;18(6):499-502.
Tohidi M, Rostami M, Asgari S, Azizi F. The association between sub-clinical hypothyroidism and metabolic syndrome: A population based study. Iranian Journal of Endocrinology and Metabolism. 2011;13(1):98-105.
Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid. 2007;17(11):1075-84.
Guntaka M, Hanmayyagari B, Rosaline M, Nagesh V. Lipid profile in subclinical hypothyroidism: A biochemical study from tertiary care hospital. CHRISMED Journal of Health and Research. 2014;1(4):266.
Qasim B, Arif S, Ahmad A, Abduljabbar R, editors. Dyslipidemia in subclinical hypothyroidism: a case-control study. Endocrine Abstracts; 2018.
Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, et al. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? European journal of endocrinology. 2001;145(6):705-10.
- Abstract Viewed: 290 times
- PDF Downloaded: 184 times